Advancing Neoantigen-Targeted Therapies with Jenosha's Atlas Platform 00:10:00
Chip Clark served as the President and Chief Executive Officer of Nasdaq-listed biopharmaceutical company, Genocea Biosciences, Inc. Prior to joining Genocea, Mr. Clark was Chief Business Officer at Vanda Pharmaceuticals Inc., a company he co-founded in 2004.